Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Gupta, Komal

Employees

1,346

Website

windlas.com

IPO Date

2021-08-16

Headquarters

705-706, Vatika Professional Point, Sector-66, Golf Course Extension Road, Gurugram, Haryana, 122001, India

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Windlas Biotech WINDLAS

Windlas Biotech Earnings Call Summary

Windlas Biotech Earnings

Transcripts

Events

About Windlas Biotech Limited

Windlas Biotech
WINDLAS